课题基金 / 基金详情

PILOT STUDY--MOLECULAR MECHANISMS OF APOLIPOPROTEIN B BIOGENESIS

PILOT STUDY--MOLECULAR MECHANISMS OF APOLIPOPROTEIN B BIOGENESIS
试点研究--载脂蛋白B生物发生的分子机制
批准号:
3732890
负责人:
VISHWANATH LINGAPPA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

VISHWANATH LINGAPPA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose to investigate the processes of apolipoprotein B (apo B) biogenesis and lipoprotein particle formation. Apolipoprotein B, synthesized in liver and intestine, plays a major role in cholesterol transport. Hypercholesterolemia is a major risk factor for atherosclerosis and coronary artery disease. A subset of patients with elevated serum cholesterol have defects in apo B structure, while many others have uncharacterized aberrations in metabolism and clearance of apo B containing lipoproteins. A molecular understanding of these defects will require detailed knowledge of the mechanism by which a normal lipoprotein particle is assembled. Despite major progress in understanding the general mechanisms of protein biogenesis, the specific process of lipoprotein assembly remains largely unknown. We will express partial and full-length cloned cDNAs encoding apo B in both membrane-supplemented cell-free systems and in living cells (Xenopus oocytes). Intermediates in apo B biogenesis, identified by pulse-chase immunoprecipitation, will be related to stages in apo B translocation across the endoplasmic reticulum membrane and lipoprotein particle assembly. These pilot studies will initiate a program aimed at dissection and reconstitution of apo B translocation, assembly, intracellular transport and secretion. Through this work will emerge a molecular description of events in the biogenesis of apo B and the lipoprotein particles with which it is associated. This understanding will ultimately provide insight into possible roles for aberrant particle assembly in lipoprotein disorders of humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NORMAL AND PATHOLOGIC CELLULAR RESPONSES TO PRION PROTEIN EXPRESSION
海外基金